| |
| |
|
| Insider
Information: |
Ryan Arthur F |
| Relationship: |
Director |
| City: |
Newark |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
384,755 |
|
|
Indirect Shares
|
462 |
|
|
| Direct
Value |
$24,843,596 |
|
|
|
Indirect Value
|
$11,562 |
|
|
| Total
Shares |
385,217 |
|
|
| Total
Value |
$24,855,159 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 22.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Prudential Financial Inc |
PJH |
Chairman, Director |
2008-02-12 |
265,366 |
2008-02-12 |
462 |
Premium* |
|
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-04-01 |
18,182 |
2010-06-14 |
0 |
Premium* |
|
|
JetPay Corporation |
JTPY |
Director |
2012-12-28 |
40,213 |
|
0 |
Premium* |
|
|
Citizens Financial Group, Inc. |
CFG |
Director |
2019-02-14 |
60,994 |
2014-09-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-04-01 |
4 |
AS |
$957.78 |
$96,253 |
D/D |
(100) |
18,182 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-03-01 |
4 |
AS |
$967.50 |
$98,205 |
D/D |
(100) |
18,282 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-01 |
4 |
AS |
$939.53 |
$95,422 |
D/D |
(100) |
18,382 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
135 |
18,482 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-02 |
4 |
AS |
$873.91 |
$89,990 |
D/D |
(100) |
18,347 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-12-01 |
4 |
AS |
$809.03 |
$81,730 |
D/D |
(100) |
18,447 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-11-07 |
4 |
AS |
$824.59 |
$82,790 |
D/D |
(100) |
18,547 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-08-01 |
4 |
AS |
$732.76 |
$73,659 |
D/D |
(100) |
18,647 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-07-03 |
4 |
AS |
$710.09 |
$71,688 |
D/D |
(100) |
18,747 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-06-01 |
4 |
AS |
$730.03 |
$73,542 |
D/D |
(100) |
18,847 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-05-01 |
4 |
AS |
$802.67 |
$80,533 |
D/D |
(100) |
18,947 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-04-03 |
4 |
AS |
$816.58 |
$81,931 |
D/D |
(100) |
19,047 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-03-01 |
4 |
AS |
$758.20 |
$76,250 |
D/D |
(100) |
19,147 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-02-01 |
4 |
AS |
$752.11 |
$75,613 |
D/D |
(100) |
19,247 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
165 |
19,347 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-03 |
4 |
AS |
$721.48 |
$72,629 |
D/D |
(100) |
19,182 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-12-01 |
4 |
AS |
$752.57 |
$75,817 |
D/D |
(100) |
19,282 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-11-01 |
4 |
AS |
$750.00 |
$75,589 |
D/D |
(100) |
19,382 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-10-03 |
4 |
AS |
$705.39 |
$72,654 |
D/D |
(100) |
19,482 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-09-06 |
4 |
AS |
$576.85 |
$58,237 |
D/D |
(100) |
19,582 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-08-04 |
4 |
S |
$620.85 |
$6,494,319 |
D/D |
(10,453) |
19,682 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-08-04 |
4 |
OE |
$374.12 |
$4,319,835 |
D/D |
10,453 |
21,092 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-08-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,500 |
19,682 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-05-02 |
4 |
AS |
$643.76 |
$65,078 |
D/D |
(100) |
22,182 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-04-01 |
4 |
AS |
$686.83 |
$69,281 |
D/D |
(100) |
22,282 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
